Paul Kelly - May 24, 2024 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Paul Kelly
Stock symbol
RLMD
Transactions as of
May 24, 2024
Transactions value $
$0
Form type
4
Date filed
5/29/2024, 09:24 PM
Previous filing
Dec 19, 2023
Next filing
Sep 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +43.7K +66.54% $0.00 109K May 24, 2024 Common Stock 43.7K $2.48 Direct F1
transaction RLMD Stock Option (right to buy) Other $0 -43.7K -39.96% $0.00 65.7K May 24, 2024 Common Stock 43.7K $2.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 43,700 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares.
F2 On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer.